marketstatsville屋友Online Offline
文章數 : 590
紀由幣 : 0
注冊日期 : 2023-03-22
Biotech Ingredients Market size is estimated to reach USD 34,057.4 million by 2030
周二 五月 30, 2023 1:27 pm
Biotech Ingredients Market size is estimated to reach USD 34,057.4 million by 2030
The Market Statsville Group (MSG) publishes the new report on the "Biotech Ingredients Market by Type (Active Pharmaceutical Ingredients and Biosimilars), by Product (Vaccines, Hormones and Growth Factors, Cytokines, Monoclonal Antibodies, Therapeutic Enzymes, Fusion Proteins, and Blood Factors), by Expression Systems (Microbial Expression Systems, Plant Expression Systems, Yeast Expression Systems, Mammalian Expression Systems, and Insect Expression Systems), by Region – Global Share and Forecast to 2030".
The global biotech ingredients market size is estimated to reach USD 34,057.4 million by 2030 from USD 23,405.7 million in 2021, registering a CAGR of 4.8% during the forecast period. The market for biotech ingredients is extremely fragmented. Biotech ingredients are substances that are made by biologically copying DNA or similar engineering compounds and have a number of advantages. This is also reflected in a significant shift in consumer preference for biotech ingredient-based products over synthetic ingredients that are hazardous to humans and the environment. The market is still at a stage where R&D activities account for a significant portion of the industry's growth. Market participants are constantly developing new products that incorporate more biotech ingredients. Moreover, demand from personal care, food & beverages, and health supplements industries act as growth drivers for the industry.
Request Sample Copy of this Report: https://www.marketstatsville.com/request-sample/biotech-ingredients-market
Global Biotech Ingredients Market Segmentation
The biotech ingredients market has been segmented into the type, product, expression systems, and region.
By Type (Active Pharmaceutical Ingredients and Biosimilars)
By Product (Vaccines, Hormones and Growth Factors, Cytokines, Monoclonal Antibodies, Fusion Proteins, Therapeutic Enzymes, and Blood Factors)
By Expression Systems (Microbial Expression Systems, Plant Expression Systems, Mammalian Expression Systems, Yeast Expression Systems, and Insect Expression Systems)
By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa)
Direct Purchase Report: https://www.marketstatsville.com/buy-now/biotech-ingredients-market?opt=3338
Microbial expression, by expression systems, is estimated to hold the largest market share
By expression systems, the global biotech ingredients market is classified into microbial expression systems, plant expression systems, mammalian expression systems, yeast expression systems, and insect expression systems. The microbial expression segment generated the highest revenue of 32.4% of the total global biotech ingredients market in 2021. The microbial expression system is the most popular system for the expression of proteins. The low-cost bacterial host expression system can be produced through simple procedures. There are around 71% recombinant membrane proteins generated from microbes. Moreover, they are available in natural resources in abundance.
Escherichia coli (E. Coli) is one of the microbes used to produce recombinant proteins. It has high growth kinetics. It also offers high cell density structures. It is also used to store and create a replicate of plasmids. Similarly, other microbes are also used for protein manufacture. Such advantages of microbial expression systems are expected to contribute toward the growth of microbial expression systems.
Access full Report Description, TOC, Table of Figure, Chart, etc: https://www.marketstatsville.com/table-of-content/biotech-ingredients-market
Europe accounts for the largest market share
Based on the regions, the market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. In 2021, Europe accounted for the highest market share of 37.2% in the global biotech ingredients market and was anticipated to maintain its dominance throughout the forecast period. The Europe biotech ingredients market is analyzed across Germany, the UK, France, Spain, Italy, Sweden, and the rest of Europe. Germany is the dominant country in the region, followed by France in terms of market share. Italy garners the lowest share in the market.
Europe is a large consumer of the product, and major quantity of domestically produced biotech ingredients are used within the region. The presence of large consumer base opting for organic and nature-based products drives demand for biotech ingredients in the region, owing to their benefit in reducing harmful side effects.
Browse the complete report: https://www.marketstatsville.com/biotech-ingredients-market
The product portfolios and winning strategies of the leading companies operating in the biotech ingredients market are studied in this research report, as well as the development and marketing strategies. It also consists of the profiles of leading companies such as Abbvie, Eli Lilly and Company, Boehringer Ingelheim, Pfizer Inc., AstraZeneca Plc., Novartis International AG, Teva Pharmaceutical Industries Ltd., Mylan, Inc., Merck & Co., and Sanofi. These market players have focused on acquisitions and expansion to gain a larger market share in the biotech ingredients market.
About Market Statsville Group
Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.
Contact US:
Eric Martin
800 Third Avenue Suite A #1519
New York, NY 10022
+1 (646) 663-5829 | India: +91-702-496-8807
Email: sales@marketstatsville.com
Web: https://marketstatsville.com/
LinkedIn | Facebook | Twitter
The Market Statsville Group (MSG) publishes the new report on the "Biotech Ingredients Market by Type (Active Pharmaceutical Ingredients and Biosimilars), by Product (Vaccines, Hormones and Growth Factors, Cytokines, Monoclonal Antibodies, Therapeutic Enzymes, Fusion Proteins, and Blood Factors), by Expression Systems (Microbial Expression Systems, Plant Expression Systems, Yeast Expression Systems, Mammalian Expression Systems, and Insect Expression Systems), by Region – Global Share and Forecast to 2030".
The global biotech ingredients market size is estimated to reach USD 34,057.4 million by 2030 from USD 23,405.7 million in 2021, registering a CAGR of 4.8% during the forecast period. The market for biotech ingredients is extremely fragmented. Biotech ingredients are substances that are made by biologically copying DNA or similar engineering compounds and have a number of advantages. This is also reflected in a significant shift in consumer preference for biotech ingredient-based products over synthetic ingredients that are hazardous to humans and the environment. The market is still at a stage where R&D activities account for a significant portion of the industry's growth. Market participants are constantly developing new products that incorporate more biotech ingredients. Moreover, demand from personal care, food & beverages, and health supplements industries act as growth drivers for the industry.
Request Sample Copy of this Report: https://www.marketstatsville.com/request-sample/biotech-ingredients-market
Global Biotech Ingredients Market Segmentation
The biotech ingredients market has been segmented into the type, product, expression systems, and region.
By Type (Active Pharmaceutical Ingredients and Biosimilars)
By Product (Vaccines, Hormones and Growth Factors, Cytokines, Monoclonal Antibodies, Fusion Proteins, Therapeutic Enzymes, and Blood Factors)
By Expression Systems (Microbial Expression Systems, Plant Expression Systems, Mammalian Expression Systems, Yeast Expression Systems, and Insect Expression Systems)
By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa)
Direct Purchase Report: https://www.marketstatsville.com/buy-now/biotech-ingredients-market?opt=3338
Microbial expression, by expression systems, is estimated to hold the largest market share
By expression systems, the global biotech ingredients market is classified into microbial expression systems, plant expression systems, mammalian expression systems, yeast expression systems, and insect expression systems. The microbial expression segment generated the highest revenue of 32.4% of the total global biotech ingredients market in 2021. The microbial expression system is the most popular system for the expression of proteins. The low-cost bacterial host expression system can be produced through simple procedures. There are around 71% recombinant membrane proteins generated from microbes. Moreover, they are available in natural resources in abundance.
Escherichia coli (E. Coli) is one of the microbes used to produce recombinant proteins. It has high growth kinetics. It also offers high cell density structures. It is also used to store and create a replicate of plasmids. Similarly, other microbes are also used for protein manufacture. Such advantages of microbial expression systems are expected to contribute toward the growth of microbial expression systems.
Access full Report Description, TOC, Table of Figure, Chart, etc: https://www.marketstatsville.com/table-of-content/biotech-ingredients-market
Europe accounts for the largest market share
Based on the regions, the market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. In 2021, Europe accounted for the highest market share of 37.2% in the global biotech ingredients market and was anticipated to maintain its dominance throughout the forecast period. The Europe biotech ingredients market is analyzed across Germany, the UK, France, Spain, Italy, Sweden, and the rest of Europe. Germany is the dominant country in the region, followed by France in terms of market share. Italy garners the lowest share in the market.
Europe is a large consumer of the product, and major quantity of domestically produced biotech ingredients are used within the region. The presence of large consumer base opting for organic and nature-based products drives demand for biotech ingredients in the region, owing to their benefit in reducing harmful side effects.
Browse the complete report: https://www.marketstatsville.com/biotech-ingredients-market
The product portfolios and winning strategies of the leading companies operating in the biotech ingredients market are studied in this research report, as well as the development and marketing strategies. It also consists of the profiles of leading companies such as Abbvie, Eli Lilly and Company, Boehringer Ingelheim, Pfizer Inc., AstraZeneca Plc., Novartis International AG, Teva Pharmaceutical Industries Ltd., Mylan, Inc., Merck & Co., and Sanofi. These market players have focused on acquisitions and expansion to gain a larger market share in the biotech ingredients market.
About Market Statsville Group
Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.
Contact US:
Eric Martin
800 Third Avenue Suite A #1519
New York, NY 10022
+1 (646) 663-5829 | India: +91-702-496-8807
Email: sales@marketstatsville.com
Web: https://marketstatsville.com/
LinkedIn | Facebook | Twitter
查看上一個這個論壇的權限：
您 無法 在這個版面回復文章
